28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 261 / 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04847453 (ClinicalTrials.gov)	September 14, 2021	15/4/2021	Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory ...	A Phase 1/1a Study of Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for Relapsed/Refracto ...	Recurrent AL Amyloidosis;Refractory AL Amyloidosis	Procedure: Bone Marrow Aspiration and Biopsy;Drug: Dexamethasone;Drug: Ixazomib Citrate;Drug: Venetoc ...	National Cancer Institute (NCI)	NULL	Recruiting	18 Years	N/A	All	6	Phase 1	United States
2	NCT03000660 (ClinicalTrials.gov)	January 2017	12/12/2016	Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis	A Phase I Trial of Venetoclax(ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyl ...	AL Amyloidosis	Drug: Venetoclax;Drug: Dexamethasone	Tufts Medical Center	NULL	Terminated	18 Years	N/A	All	3	Phase 1	United States

First Previous1Next Last